S&P Midcap 400 Portfolio (^MID, MDY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : S&P Midcap 400 Portfolio (^MID, MDY)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Londo who started this subject	5/8/2001 3:05:34 AM
From: Londo	of 181

INCY opened at $18.35 today, and rose to hit my limit target of $18.50. So, as per the instructions on message #21, 41 shares of INCY were sold for $18.50. This adds another $758.50 worth of cash in the portfolio. This leaves 38.5% of the portfolio in cash, and 25.2% of the portfolio in biotechnology. The other allocations described in the previous message are the same. There is still the outstanding stop-loss order on CORR for 27 dollars a share. This order remains, although I doubt it will be hit by the expiration on March 18th. Still looking for the correct moment to invest the cash. Right now, the 'wait and see' approach is prudent.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next